Relation of Circulating Osteoprotegerin Levels on Admission to Microvascular Obstruction After Primary Percutaneous Coronary Intervention

Dec 22, 2016 by in CARDIOLOGY Comments Off on Relation of Circulating Osteoprotegerin Levels on Admission to Microvascular Obstruction After Primary Percutaneous Coronary Intervention

Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, has recently been linked to atherosclerosis and development of postinfarction heart failure. This study was designed to assess…

read more

Three-Year Results of Safety and Efficacy of the Everolimus -Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)

Dec 22, 2016 by in CARDIOLOGY Comments Off on Three-Year Results of Safety and Efficacy of the Everolimus -Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)

Women treated with the XIENCE V have improved 1-year clinical outcomes compared to women treated with TAXUS; whether benefits in women are sustained at 3 years is unknown. Three-year follow-up…

read more

Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Dec 22, 2016 by in CARDIOLOGY Comments Off on Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Complete blood count is the most widely available laboratory datum in the early in-hospital period after ST-elevation myocardial infarction (STEMI). We assessed the clinical utility of the combined use of…

read more

Long-Term (Three-Year) Safety and Efficacy of Everolimus -Eluting Stents Compared to Paclitaxel -Eluting Stents (from the SPIRIT III Trial)

Dec 22, 2016 by in CARDIOLOGY Comments Off on Long-Term (Three-Year) Safety and Efficacy of Everolimus -Eluting Stents Compared to Paclitaxel -Eluting Stents (from the SPIRIT III Trial)

The safety and efficacy of the XIENCE V everolimus-eluting stent (EES) compared to the Taxus Express paclitaxel-eluting stent (PES) has been demonstrated through 2 years in the SPIRIT II and…

read more

Placental Growth Factor and B-Type Natriuretic Peptide as Independent Predictors of Risk from a Multibiomarker Panel in Suspected Acute Coronary Syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) Study

Dec 22, 2016 by in CARDIOLOGY Comments Off on Placental Growth Factor and B-Type Natriuretic Peptide as Independent Predictors of Risk from a Multibiomarker Panel in Suspected Acute Coronary Syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) Study

Most patients presenting to the emergency department with possible cardiac symptoms have low cardiac troponin (cTn) concentrations. A combination of biomarkers that improves risk stratification in patients at very low…

read more

Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)

Dec 22, 2016 by in CARDIOLOGY Comments Off on Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)

The BEAUTIFUL Holter substudy explored the cardiac safety of the I f inhibitor ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction receiving optimal background therapy….

read more

Gender Differences Between the Minnesota Code and Novacode Electrocardiographic Prognostication of Coronary Heart Disease in the Cardiovascular Health Study

Dec 22, 2016 by in CARDIOLOGY Comments Off on Gender Differences Between the Minnesota Code and Novacode Electrocardiographic Prognostication of Coronary Heart Disease in the Cardiovascular Health Study

The Minnesota Code (MC) and Novacode (Nova) are the most widely used electrocardiographic (ECG) classification systems. The comparative strengths of their classifications for Q- and ST-T–wave abnormalities in predicting coronary…

read more

Mortality in Individuals Without Known Coronary Artery Disease but With Discordance Between the Framingham Risk Score and Coronary Artery Calcium

Dec 22, 2016 by in CARDIOLOGY Comments Off on Mortality in Individuals Without Known Coronary Artery Disease but With Discordance Between the Framingham Risk Score and Coronary Artery Calcium

A risk-management approach based on the Framingham risk score (FRS), although useful in preventing future coronary artery disease (CAD) events, is unable to identify a considerable portion of patients with…

read more
Get Clinical Tree app for offline access